Woodline Partners’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-170,230
| Closed | -$1.17M | – | 466 |
|
|
2023
Q3 | $1.17M | Buy |
170,230
+68,731
| +68% | +$471K | 0.01% | 434 |
|
|
2023
Q2 | $1.05M | Sell |
101,499
-124,703
| -55% | -$1.29M | 0.01% | 479 |
|
|
2023
Q1 | $1.83M | Sell |
226,202
-376,317
| -62% | -$3.04M | 0.02% | 430 |
|
|
2022
Q4 | $9.49M | Sell |
602,519
-94,488
| -14% | -$1.49M | 0.13% | 219 |
|
|
2022
Q3 | $11M | Buy |
697,007
+75,450
| +12% | +$1.19M | 0.15% | 188 |
|
|
2022
Q2 | $8.68M | Buy |
+621,557
| New | +$8.68M | 0.13% | 192 |
|
|
2021
Q4 | – | Sell |
-594,768
| Closed | -$10.7M | – | 700 |
|
|
2021
Q3 | $10.7M | Buy |
+594,768
| New | +$10.7M | 0.17% | 151 |
|